Human keratinocytes respond to interleukin-18: Implication for the course of chronic inflammatory skin diseases

Journal of Investigative Dermatology

Volumn 124, Issue 6, 2005, Pages 1225-1233

  Wittmann, Miriam ^a   Purwar, Rahul ^a   Hartmann, Christina ^a   Gutzmer, Ralf ^a   Werfel, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CD4+ T lymphocytes; Chemokines; Inflammation; MHC

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CELL STIMULATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ECZEMA; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; RECEPTOR DOWN REGULATION; SKIN BIOPSY; SKIN INFLAMMATION; T LYMPHOCYTE;

EID: 20544448597     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23715.x     Document Type: Article

References (62)

1. Adachi O, Kawai T, Takeda K, et al: Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9:143-150, (1998
2. Akira S: The role of IL-18 in innate immunity. Curr Opin Immunol 12:59-63, 2000
3. Akita K, Ohtsuki T, Nukada Y, et al: Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J Biol Chem 272:26595-26603, 1997
4. Albanesi C, Scarponi C, Sebastian: S, et al: IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 165:1395-1402, 2000
5. Bonecchi R, Bianchi G, Bordignon PP, et al: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134, 1998
6. Boorsma DM, Flier J, Sampat S, et al: Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res 290:335-341, 1998
7. Born TL, Thomassen E, Bird TA, Sims JE: Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 273:29445-29450, 1998
8. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM: The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 30:1113-1119, 2000
9. Cho YS, Kang JW, Cho M, et al: Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett 501:139-145, 2001
10. Companjen AR, Prens E, Mee JB, Groves RW: Expression of IL-18 in human keratinocytes. J Invest Dermatol 114:598-599, 2000
11. Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I: Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1 beta-dependent mechanism. Immunology 102:323-330, 2001
12. Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K: Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: Implications in rheumatoid arthritis. Arthritis Rheum 50:432-443, 2004
13. Dinarello CA: IL-18: ATH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103:11-24, 1999
14. El Mezzein RE, Matsumoto T, Nomiyama H, Miike T: Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 126:193-198, 2001
15. Fan L, Busser BW, Lifsted TQ, Oukka M, Lo D, Laufer TM: Antigen presentation by keratinocytes directs autoimmune skin disease. Proc Natl Acad Sci USA 100:3386-3391, 2003
16. Foulds S: Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells. Cytometry 29:182-186, 1997
17. Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M: Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73:2401-2409, 1999
18. Gangemi S, Merendino RA, Guarneri F, Minciullo PL, DiLorenzo G, Pacor M, Cannavo SP: Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: Preliminary considerations. J Eur Acad Dermatol Venereoll 7:42-46, 2003
19. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U: Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for atherogenesis. J Exp Med 195:245-257, 2002
20. Gracie JA, Robertson SE, McInnes IB: Interleukin-18. J Leukoc Biol 73:213-224, 2003
21. Gutzmer R, Langer K, Mommert S, Wittmann M, Kapp A, Werfel T: Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol 171:6363-6371, 2003
22. Harandi AM, Svennerholm B, Holmgren J, Eriksson K: Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J Virol 75: 6705-6709, 2001
23. Hoshino T, Wiltrout RH, Young HA: IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response. J Immunol 162:5070-5077, 1999
24. Hoshino T, Yagita H, Ortaldo JR, Wiltrout RH, Young HA: In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and upregulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol 30:1998-2006, 2000
25. Kalina U, Kauschat D, Koyama N, et al: IL-18 activates STATS in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J Immunol 165:1307-1313, 2000
26. Koizumi H, Sato-Matsumura KC, Nakamura H, et al: Distribution of IL-18 and IL-18 receptor in human skin: Various forms of IL-18 are produced in keratinocytes. Arch Dermatol Res 293:325-333, 2001
27. Kojima H, Aizawa Y, Yanai Y, et al: An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol 162:5063-5069, 1999
28. Konishi H, Tsutsui H, Murakami T, et al: IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 99:11340-11345, 2002
29. Kruse S, Kuehr J, Moseler M, et al: Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 111:117-122, 2003
30. Lebre MC, Antons JC, Kalinski P, Schuitemaker JH, van Capel TM, Kapsenberg ML, De Jong EC: Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarized phenotype in dendritic cells: Role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18. J Invest Dermatol 120:990-997, 2003
31. Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, Dinarello CA: Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci USA 101:8815-8820, 2004
32. Leung DY, Bieber T: Atopic dermatitis. Lancet 361:151-160, 2003
33. Leung DY, Travers JB, Norris DA: The role of superantigens in skin disease. J Invest Dermatol 105:373-423, 1995
34. Malmgaard L, Paludan SR: Interferon (IFN)-alpha/beta, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-gamma during infection with herpes simplex virus type 2. J Gen Virol 84:2497-2500, 2003
35. Matsui K, Yoshimoto T, Tsutsui H, et al: Propionibacterium acnes treatment diminishes CD4+NK1.1+ T cells but induces type I Tcells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 159:97-106, 1997
36. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY: Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol Today 21:312-315, 2000
37. Mee JB, Alam Y, Groves RW: Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol 143:330-336, 2000
38. Morel JC, Park CC, Woods JM, Koch AE: A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem 276:37069-37075, 2001
39. Morel JC, Park CC, Zhu K, Kumar P, Ruth JH, Koch AE: Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J Biol Chem 277:34679-34691, 2002
40. Muhl H, Kampfer H, Bosmann M, Frank S, Radeke H, Pfeilschifter J: Interferon-gamma mediates gene expression of IL-18 binding protein in non-leukocytic cells. Biochem Biophys Res Commun 267:960-963, 2000
41. Naik SM, Cannon G, Burbach GJ, et al: Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J Invest Dermatol 113:766-772, 1999
42. Nakahira M, Ahn HJ, Park WR, et al: Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168:1146-1153, 2002
43. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474, 2001
44. Novak N, Valenta R, Bohle B, Laffer S, Haberstok J, Kraft S, Bieber T: FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113: 949-957, 2004
45. Ohta Y, Hamada Y, Katsuoka K: Expression of IL-18 in psoriasis. Arch Dermatol Res 293:334-342, 2001
46. Pan G, Risser P, Mao W, et al: IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 13:1-7, 2001
47. Pietrzak A, Lecewicz-Torun B, Chodorowska G, Rolinski J: Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. Acta Derm Venereol 83:262-265, 2003
48. Sareneva T, Julkunen I, Matikainen S: IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 165:1933-1938, 2000
49. Schwarz A, Stander S, Berneburg M, et al: Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 4: 26-31, 2002
50. Smeltz RB, Chen J, Ehrhardt R, Shevach EM: Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J Immunol 168:6165-6172, 2002
51. Smeltz RB, Chen J, Hu-Li J, Shevach EM: Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4. J Exp Med 194:143-153, 2001
52. Tanaka T, Tsutsui H, Yoshimoto T, et al: Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis modei mice, NC/Nga. Int Arch Allergy Immunol 125:236-240, 2001
53. Torigoe K, Ushio S, Okura T, et al: Purification and characterization of the human interleukin-18 receptor. J Biol Chem 272:25737-25742, 1997
54. van Rietschoten JG, Smits HH, van de WD, Westland R, Verweij CL, den Hartog MT, Wierenga EA: Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells. J Biol Chem 276: 34509-34516, 2001
55. Wittmann M, Alter M, Stünkel T, Kapp A, Werfel T: Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a Th1 response. J Allergy Clin Immunol 114:965-973, 2004
56. Wittmann M, Kienlin P, Mommert S, Kapp A, Werfel T: Suppression of IL-12 production by soluble CD40 ligand: Evidence for involvement of the p44/42 mitogen-activated protein kinase pathway. J Immunol 168:3793-3800, 2002
57. Xu D, Chan WL, Leung BP, et al: Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 188: 1485-1492, 1998
58. Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M: Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 168:2020-2027, 2002
59. Yamanaka K, Tanaka M, Tsutsui H, et al: Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 165:997-1003, 2000
60. Yoshimoto T, Mizutani H, Tsutsui H, et al: IL-18 induction of IgE: Dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 1:132-137, 2000
61. Yoshimoto T, Takeda K, Tanaka T, et al: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production. J Immunol 161:3400-3407, 1998
62. Yoshimoto T, Tsutsui H, Tominaga K, et al: IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 96:13962-13966, 1999